- PEP06

Since January 2013, PharmaEngine is collaborating with Guangzhou BeBetter Medicine with the aim of discovering, selecting and developing new chemical entities against predefined targets in oncology.

The partnership with BeBetter represents an important step of PharmaEngine in developing new drugs through cross-strait cooperation. Combining BeBetter’s expertise in drug research with our expertise in drug development offers multiple synergistic benefits, which will increase overall efficiency and profitability.

The development goal is to develop patentable chemical entities or analogs with specific mechanisms in oncology, then select suitable candidates for clinical trials.